Dongming Cai, MD, PhD
img_Dongming Cai
Research Topics
Alzheimer's Disease
Multi-Disciplinary Training Area
Disease Mechanisms and Therapeutics (DMT), Neuroscience [NEU]
Pathogenesis of Alzheimer's Disease
Dr. Cai’s laboratory conducts research studies focusing on the pathogenesis of Alzheimer’s disease. Using transgenic animal models, her research group investigates the molecular and cellular mechanisms underlying amyloid generation, with the goal of developing new diagnostic and therapeutic tools for Alzheimer's disease.


ADPD Junior Faculty Award


New Investigator Research Award

Alzheimer's Association


Career Development Award

Department of Veterans Affairs

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Cai during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Royalty Payments:

  • U.S. Department of Veterans Affairs

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.